Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China

BACKGROUND: Pyrazinamide still may be a useful drug for treatment of rifampin-resistant (RR-TB) or multidrug-resistant tuberculosis (MDR-TB) in China while awaiting scale up of new drugs and regimens including bedaquiline and linezolid. The level of pyrazinamide resistance among MDR-TB patients in C...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Hui, van den Hof, Susan, Cobelens, Frank, Zhou, Yang, Zhao, Bing, Wang, Shengfen, Zhao, Yanlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947908/
https://www.ncbi.nlm.nih.gov/pubmed/31910878
http://dx.doi.org/10.1186/s12879-020-4758-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947908/
https://www.ncbi.nlm.nih.gov/pubmed/31910878
http://dx.doi.org/10.1186/s12879-020-4758-9

Ejemplares similares